{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:05:27Z","timestamp":1790759127947,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02941-0","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:34:14Z","timestamp":1781328854000},"page":"2825-2843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Altered serum amylin and preptin levels in women with polycystic ovary syndrome: a comparative analysis based on obesity status"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1500-1148","authenticated-orcid":false,"given":"Lanya Mohammed","family":"Nasralddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-300X","authenticated-orcid":false,"given":"Shwan Majid","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"12","key":"2941_CR1","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.3390\/app11125395","volume":"11","author":"ML S\u00e1nchez-Ferrer","year":"2021","unstructured":"S\u00e1nchez-Ferrer ML et al (2021) Anthropometric characteristics of polycystic ovary syndrome and their associations with insulin resistance and lipid profile. Appl Sci 11(12):5395. https:\/\/doi.org\/10.3390\/app11125395","journal-title":"Appl Sci"},{"key":"2941_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.endmts.2025.100228","volume":"17","author":"A Ghafari","year":"2025","unstructured":"Ghafari A et al (2025) The last update on polycystic ovary syndrome (PCOS), diagnosis criteria, and novel treatment. Endocr Metab Sci 100228. https:\/\/doi.org\/10.1016\/j.endmts.2025.100228","journal-title":"Endocr Metab Sci"},{"key":"2941_CR3","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.12659\/MSM.912957","volume":"24","author":"\u015e \u015eent\u00fcrk","year":"2018","unstructured":"\u015eent\u00fcrk \u015e, Hatirnaz S, Kanat-Pekta\u015f M (2018) Serum preptin and amylin levels with respect to body mass index in polycystic ovary syndrome patients. Med Sci Monitor: Int Med J Experimental Clin Res 24:7517. https:\/\/doi.org\/10.12659\/MSM.912957","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"1","key":"2941_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12944-020-01410-8","volume":"19","author":"A Kheirollahi","year":"2020","unstructured":"Kheirollahi A et al (2020) Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Lipids Health Dis 19(1):235. https:\/\/doi.org\/10.1186\/s12944-020-01410-8","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2941_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/S0954422416000287","volume":"30","author":"YM Jeanes","year":"2017","unstructured":"Jeanes YM, Reeves S (2017) Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev 30(1):97\u2013105. https:\/\/doi.org\/10.1017\/S0954422416000287","journal-title":"Nutr Res Rev"},{"issue":"3","key":"2941_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"Stepto NK et al (2013) Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic\u2013hyperinsulaemic clamp. Hum Reprod 28(3):777\u2013784. https:\/\/doi.org\/10.1093\/humrep\/des463","journal-title":"Hum Reprod"},{"key":"2941_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, Tarlatzis BC, Kauffman RP (2018) Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism 86:33\u201343. https:\/\/doi.org\/10.1016\/j.metabol.2017.09.016","journal-title":"Metabolism"},{"key":"2941_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2025.09.025","author":"A Dokras","year":"2025","unstructured":"Dokras A (2025) PCOS in 2025\u2013Insights and Innovations. Fertil Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.09.025","journal-title":"Fertil Steril"},{"issue":"1","key":"2941_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.fertnstert.2009.02.086","volume":"94","author":"S James","year":"2010","unstructured":"James S, Moralez J, Nagamani M (2010) Increased secretion of amylin in women with polycystic ovary syndrome. Fertil Steril 94(1):211\u2013215. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.086","journal-title":"Fertil Steril"},{"issue":"12","key":"2941_CR10","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","volume":"69","author":"TA Lutz","year":"2012","unstructured":"Lutz TA (2012) Control of energy homeostasis by amylin. Cell Mol Life Sci 69(12):1947\u20131965. https:\/\/doi.org\/10.1007\/s00018-011-0905-1","journal-title":"Cell Mol Life Sci"},{"key":"2941_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.molmet.2017.11.009","volume":"8","author":"CN Boyle","year":"2018","unstructured":"Boyle CN, Lutz TA, Le Foll C (2018) Amylin\u2013Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity. Mol metabolism 8:203\u2013210. https:\/\/doi.org\/10.1016\/j.molmet.2017.11.009","journal-title":"Mol metabolism"},{"issue":"4","key":"2941_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/osp4.62","volume":"2","author":"J Trevaskis","year":"2016","unstructured":"Trevaskis J et al (2016) Amylin\/leptin synergy is absent in extreme obesity and not restored by calorie restriction-induced weight loss in rats. Obes Sci Pract 2(4):385\u2013391. https:\/\/doi.org\/10.1002\/osp4.62","journal-title":"Obes Sci Pract"},{"issue":"6","key":"2941_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/09513590.2017.1409715","volume":"34","author":"A Mierzwicka","year":"2018","unstructured":"Mierzwicka A et al (2018) Preptin in women with polycystic ovary syndrome. Gynecol Endocrinol 34(6):470\u2013475. https:\/\/doi.org\/10.1080\/09513590.2017.1409715","journal-title":"Gynecol Endocrinol"},{"key":"2941_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.peptides.2014.03.021","volume":"56","author":"S Aydin","year":"2014","unstructured":"Aydin S (2014) Three new players in energy regulation: preptin, adropin and irisin. Peptides 56:94\u2013110. https:\/\/doi.org\/10.1016\/j.peptides.2014.03.021","journal-title":"Peptides"},{"issue":"11","key":"2941_CR15","first-page":"3005","volume":"10","author":"HaA Ali","year":"2018","unstructured":"Ali HaA, Abbas HJ, Naser NA (2018) Preptin and adropin levels as new predictor in women with polycystic ovary syndrome. J Pharm Sci Res 10(11):3005\u20133008 (no DOI available)","journal-title":"J Pharm Sci Res"},{"issue":"1","key":"2941_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-7827-10-1","volume":"10","author":"Z Bu","year":"2012","unstructured":"Bu Z et al (2012) The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level. Reproductive biology Endocrinol 10(1):10. https:\/\/doi.org\/10.1186\/1477-7827-10-1","journal-title":"Reproductive biology Endocrinol"},{"issue":"4","key":"2941_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1210\/er.2017-00111","volume":"38","author":"MW Schwartz","year":"2017","unstructured":"Schwartz MW et al (2017) Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev 38(4):267\u2013296. https:\/\/doi.org\/10.1210\/er.2017-00111","journal-title":"Endocr Rev"},{"issue":"11","key":"2941_CR18","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.3390\/nu6115153","volume":"6","author":"Y Zhang","year":"2014","unstructured":"Zhang Y et al (2014) Obesity: pathophysiology and intervention. Nutrients 6(11):5153\u20135183. https:\/\/doi.org\/10.3390\/nu6115153","journal-title":"Nutrients"},{"key":"2941_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2025.100375","volume":"27","author":"SK Ahmed","year":"2025","unstructured":"Ahmed SK, Mohammed RA (2025) Obesity: prevalence, causes, consequences, management, preventive strategies and future research directions. Metab Open 100375. https:\/\/doi.org\/10.1016\/j.metop.2025.100375","journal-title":"Metab Open"},{"issue":"1","key":"2941_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13098-019-0468-0","volume":"11","author":"C Cercato","year":"2019","unstructured":"Cercato C, Fonseca F (2019) Cardiovascular risk and obesity. Diabetol Metab Syndr 11(1):74. https:\/\/doi.org\/10.1186\/s13098-019-0468-0","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"2941_CR21","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/jpm13091319","volume":"13","author":"M L\u00f3pez-Alarc\u00f3n","year":"2023","unstructured":"L\u00f3pez-Alarc\u00f3n M et al (2023) Obesity and hyperandrogenemia in polycystic ovary syndrome: clinical implications. J Personalized Med 13(9):1319. https:\/\/doi.org\/10.3390\/jpm13091319","journal-title":"J Personalized Med"},{"issue":"4","key":"2941_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7570\/jomes24035","volume":"33","author":"JJ Kim","year":"2024","unstructured":"Kim JJ (2024) Obesity and polycystic ovary syndrome. J Obes Metabolic Syndrome 33(4):289. https:\/\/doi.org\/10.7570\/jomes24035","journal-title":"J Obes Metabolic Syndrome"},{"issue":"15","key":"2941_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14715\/cmb\/2017.64.15.2","volume":"64","author":"N Celik","year":"2018","unstructured":"Celik N et al (2018) Patatin-like phospholipase domain containing 3-gene (adiponutrin), preptin, kisspeptin and amylin regulates oocyte developmental capacity in PCOS. Cell Mol Biol 64(15):7\u201312. https:\/\/doi.org\/10.14715\/cmb\/2017.64.15.2","journal-title":"Cell Mol Biol"},{"issue":"3","key":"2941_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.57238\/jbb.2023.7061.1045","volume":"2","author":"Z Alobaidy","year":"2023","unstructured":"Alobaidy Z, Alammar H (2023) Evaluation of lipid profile, and preptin between obese non-diabetic patients and women with polycystic ovary syndrome in Al Diwaniyah, Iraq. J Biomed Biochem 2(3):45\u201354. https:\/\/doi.org\/10.57238\/jbb.2023.7061.1045","journal-title":"J Biomed Biochem"},{"issue":"1","key":"2941_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"TR ESHRE","year":"2004","unstructured":"ESHRE TR, Group A-SPCW (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"issue":"1","key":"2941_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijt.ijt_93_16","volume":"9","author":"R Aswini","year":"2017","unstructured":"Aswini R, Jayapalan S (2017) Modified Ferriman\u2013Gallwey score in hirsutism and its association with metabolic syndrome. Int J trichology 9(1):7\u201313. https:\/\/doi.org\/10.4103\/ijt.ijt_93_16","journal-title":"Int J trichology"},{"key":"2941_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.1568","author":"LO Gostin","year":"2023","unstructured":"Gostin LO (2023) The World Health Organization on its 75th anniversary. JAMA Health Forum. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.1568","journal-title":"JAMA Health Forum"},{"key":"2941_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003680","author":"H Hu","year":"2024","unstructured":"Hu H et al (2024) Should insulin resistance (HOMA-IR), insulin secretion (HOMA-\u03b2), and visceral fat area be considered for improving the performance of diabetes risk prediction models. BMJ Open Diabetes Res Care. https:\/\/doi.org\/10.1136\/bmjdrc-2023-003680","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"9","key":"2941_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.29271\/jcpsp.2021.09.1015","volume":"31","author":"AI Paracha","year":"2021","unstructured":"Paracha AI et al (2021) Diagnostic accuracy of markers of insulin resistance (HOMA-IR) and insulin sensitivity (QUICKI) in gestational diabetes. J Coll Physicians Surg Pak 31(9):1015\u20131019. https:\/\/doi.org\/10.29271\/jcpsp.2021.09.1015","journal-title":"J Coll Physicians Surg Pak"},{"issue":"6","key":"2941_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000479371","volume":"88","author":"L Ib\u00e1\u00f1ez","year":"2017","unstructured":"Ib\u00e1\u00f1ez L et al (2017) An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Hormone Res paediatrics 88(6):371\u2013395. https:\/\/doi.org\/10.1159\/000479371","journal-title":"Hormone Res paediatrics"},{"key":"2941_CR31","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2024-0117","author":"CE Gonz\u00e1lez-Sandoval","year":"2024","unstructured":"Gonz\u00e1lez-Sandoval CE et al (2024) Triglyceride\/high-density cholesterol ratio as a predictor of cardiometabolic risk in young population. J Med Life. https:\/\/doi.org\/10.25122\/jml-2024-0117","journal-title":"J Med Life"},{"issue":"5","key":"2941_CR32","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA (2018) Correlation coefficients: appropriate use and interpretation. Anesth analgesia 126(5):1763\u20131768. https:\/\/doi.org\/10.1213\/ANE.0000000000002864","journal-title":"Anesth analgesia"},{"issue":"2","key":"2941_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F et al (2007) G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175\u2013191. https:\/\/doi.org\/10.3758\/BF03193146","journal-title":"Behav Res Methods"},{"issue":"2","key":"2941_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jtumed.2016.11.005","volume":"12","author":"HR Chitme","year":"2017","unstructured":"Chitme HR et al (2017) Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome. J Taibah Univ Med Sci 12(2):139\u2013145. https:\/\/doi.org\/10.1016\/j.jtumed.2016.11.005","journal-title":"J Taibah Univ Med Sci"},{"key":"2941_CR35","doi-asserted-by":"publisher","first-page":"1085656","DOI":"10.3389\/fendo.2022.1085656","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H et al (2023) Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Front Endocrinol 13:1085656. https:\/\/doi.org\/10.3389\/fendo.2022.1085656","journal-title":"Front Endocrinol"},{"issue":"1","key":"2941_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12958-023-01160-z","volume":"21","author":"L Rahmatnezhad","year":"2023","unstructured":"Rahmatnezhad L et al (2023) Association of insulin resistance with polycystic ovary syndrome phenotypes and patients\u2019 characteristics: a cross-sectional study in Iran. Reproductive Biology Endocrinol 21(1):113. https:\/\/doi.org\/10.1186\/s12958-023-01160-z","journal-title":"Reproductive Biology Endocrinol"},{"key":"2941_CR37","doi-asserted-by":"publisher","unstructured":"Mumin B et al (2023) Deciphering gynaecological pathologies in women with acne and alopecia. African Journal of Reproductive Health\/La Revue Africaine de la Sant\u00e9 Reproductive. 27(5):30\u201340. https:\/\/doi.org\/10.29063\/ajrh2023\/v27i5.3","DOI":"10.29063\/ajrh2023\/v27i5.3"},{"issue":"1","key":"2941_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1089\/whr.2023.0176","volume":"5","author":"F Alkhezi","year":"2024","unstructured":"Alkhezi F et al (2024) Prevalence of and risk factors associated with polycystic ovary syndrome among female university students of health sciences in a middle eastern country. Women\u2019s Health Rep 5(1):579\u2013587. https:\/\/doi.org\/10.1089\/whr.2023.0176","journal-title":"Women\u2019s Health Rep"},{"issue":"2","key":"2941_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/ijem.IJEM_637_18","volume":"23","author":"G Sachdeva","year":"2019","unstructured":"Sachdeva G et al (2019) Obese and non-obese polycystic ovarian syndrome: comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene. Indian J Endocrinol Metabol 23(2):257\u2013262. https:\/\/doi.org\/10.4103\/ijem.IJEM_637_18","journal-title":"Indian J Endocrinol Metabol"},{"issue":"3","key":"2941_CR40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/humupd\/dmt061","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D et al (2014) Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 20(3):334\u2013352. https:\/\/doi.org\/10.1093\/humupd\/dmt061","journal-title":"Hum Reprod Update"},{"key":"2941_CR41","doi-asserted-by":"publisher","unstructured":"Teede HJ et al (2023) International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023. https:\/\/doi.org\/10.1093\/ejendo\/lvad096","DOI":"10.1093\/ejendo\/lvad096"},{"issue":"09","key":"2941_CR42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1055\/a-1880-1264","volume":"54","author":"N Kumar","year":"2022","unstructured":"Kumar N, Agarwal H (2022) Early clinical, biochemical and radiological features in obese and non-obese young women with polycystic ovarian syndrome: a comparative study. Horm Metab Res 54(09):620\u2013624. https:\/\/doi.org\/10.1055\/a-1880-1264","journal-title":"Horm Metab Res"},{"issue":"1","key":"2941_CR43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0889-8545(00)80005-4","volume":"27","author":"C Sengos","year":"2000","unstructured":"Sengos C, Andreakos C, Iatrakis G (2000) Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome. Clin Exp Obstet Gynecol 27(1):35\u201338","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"6","key":"2941_CR44","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.3390\/ijerph18062977","volume":"18","author":"ML S\u00e1nchez-Ferrer","year":"2021","unstructured":"S\u00e1nchez-Ferrer ML et al (2021) Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes. A Preliminar Case-Control Study. Int J Environ Res Public Health 18(6):2977. https:\/\/doi.org\/10.3390\/ijerph18062977","journal-title":"Int J Environ Res Public Health"},{"key":"2941_CR45","doi-asserted-by":"publisher","first-page":"892125","DOI":"10.3389\/fendo.2022.892125","volume":"13","author":"F Guo","year":"2022","unstructured":"Guo F et al (2022) The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population. Front Endocrinol 13:892125. https:\/\/doi.org\/10.3389\/fendo.2022.892125","journal-title":"Front Endocrinol"},{"key":"2941_CR46","unstructured":"Ebrahimi-Mamaghani M et al (2015) Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome. Journal of Health, Population, and Nutrition, 33(1):157. PMID: 25995732"},{"issue":"2","key":"2941_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.18585\/inabj.v17i2.3530","volume":"17","author":"KH Haddawi","year":"2025","unstructured":"Haddawi KH et al (2025) Insulin Resistance, Adiponectin, and Dyslipidemia as Key Determinants of Metabolic and Reproductive Dysregulation in Polycystic Ovary Syndrome. Indonesian Biomedical J 17(2):125\u2013133. https:\/\/doi.org\/10.18585\/inabj.v17i2.3530","journal-title":"Indonesian Biomedical J"},{"key":"2941_CR48","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20230783","author":"N Sethi","year":"2023","unstructured":"Sethi N, Puri S, Malhotra A (2023) A comparative study of insulin levels in lean versus obese polycystic ovarian syndrome patients. Int J Reprod Contracept Obstet Gynecol. https:\/\/doi.org\/10.18203\/2320-1770.ijrcog20230783","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"4","key":"2941_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S (2021) Obesity and polycystic ovary syndrome. Clin Endocrinol 95(4):531\u2013541. https:\/\/doi.org\/10.1111\/cen.14421","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2941_CR50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.21608\/ejhm.2020.70969","volume":"78","author":"TA Ibrahim","year":"2020","unstructured":"Ibrahim TA, Ali, Radwan ME-H (2020) Lipid profile in women with polycystic ovary syndrome. Egypt J Hosp Med 78(2):272\u2013277. https:\/\/doi.org\/10.21608\/ejhm.2020.70969","journal-title":"Egypt J Hosp Med"},{"key":"2941_CR51","unstructured":"Purohit P, Zahir F, Das DN, Priyanka (2024) Study of lipid profile in obese and lean women with polycystic ovarian syndrome in a tertiary hospital of Northeast India. International Journal of Pharmaceutical and Clinical Research, 16(8):546\u2013549"},{"key":"2941_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70160","author":"E Zabieg\u0142o","year":"2025","unstructured":"Zabieg\u0142o E, Jach R, Pir\u00f3g M (2025) Age and BMI-related changes in hormonal profile in women with polycystic ovary syndrome (PCOS): Association with infertility. Int J Gynecol Obstet. https:\/\/doi.org\/10.1002\/ijgo.70160","journal-title":"Int J Gynecol Obstet"},{"key":"2941_CR53","doi-asserted-by":"publisher","unstructured":"Thejeel LK, Ali ZA, Hussein HK (2024) Association between Amylin and Visfatin in patients with Polycystic Ovarian Syndrome In Babylon province. Journals Kufa Chamical 4(1). https:\/\/doi.org\/10.36329\/jkcm\/2024\/v4.i1.14715","DOI":"10.36329\/jkcm\/2024\/v4.i1.14715"},{"issue":"1","key":"2941_CR54","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.fertnstert.2010.08.058","volume":"95","author":"O Celik","year":"2011","unstructured":"Celik O et al (2011) An appraisal of serum preptin levels in PCOS. Fertil Steril 95(1):314\u2013316. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.08.058","journal-title":"Fertil Steril"},{"issue":"11","key":"2941_CR55","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/09513590.2017.1342165","volume":"33","author":"AR Pande","year":"2017","unstructured":"Pande AR et al (2017) \u03b2 cell function and insulin resistance in lean cases with polycystic ovary syndrome. Gynecol Endocrinol 33(11):877\u2013881. https:\/\/doi.org\/10.1080\/09513590.2017.1342165","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2941_CR56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12902-024-01720-3","volume":"24","author":"J Nayeem","year":"2024","unstructured":"Nayeem J et al (2024) Insulin resistance and insulin secretory defect among Bangalee PCOS women: A case-control study. BMC Endocr Disorders 24(1):207. https:\/\/doi.org\/10.1186\/s12902-024-01720-3","journal-title":"BMC Endocr Disorders"},{"issue":"6","key":"2941_CR57","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s13300-025-01733-8","volume":"16","author":"\u0160 Vol\u010dan\u0161ek","year":"2025","unstructured":"Vol\u010dan\u0161ek \u0160 et al (2025) Amylin: from mode of action to future clinical potential in diabetes and obesity. Diabetes Therapy 16(6):1207\u20131227. https:\/\/doi.org\/10.1007\/s13300-025-01733-8","journal-title":"Diabetes Therapy"},{"issue":"3","key":"2941_CR58","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/molecules27031021","volume":"27","author":"DC Bhowmick","year":"2022","unstructured":"Bhowmick DC et al (2022) Molecular mechanisms of amylin turnover, misfolding and toxicity in the pancreas. Molecules 27(3):1021. https:\/\/doi.org\/10.3390\/molecules27031021","journal-title":"Molecules"},{"issue":"4","key":"2941_CR59","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/biof.1623","volume":"46","author":"J van Doorn","year":"2020","unstructured":"van Doorn J (2020) Insulin-like growth factor\u2010II and bioactive proteins containing a part of the E\u2010domain of pro\u2010insulin\u2010like growth factor\u2010II. BioFactors 46(4):563\u2013578. https:\/\/doi.org\/10.1002\/biof.1623","journal-title":"BioFactors"},{"key":"2941_CR60","doi-asserted-by":"publisher","first-page":"107201","DOI":"10.1016\/j.bpc.2024.107201","volume":"308","author":"G Mazzini","year":"2024","unstructured":"Mazzini G et al (2024) The processing intermediate of human amylin, pro-amylin (1\u201348), has in vivo and in vitro bioactivity. Biophys Chem 308:107201. https:\/\/doi.org\/10.1016\/j.bpc.2024.107201","journal-title":"Biophys Chem"},{"issue":"9","key":"2941_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13090991","volume":"13","author":"M-C Ungureanu","year":"2023","unstructured":"Ungureanu M-C et al (2023) Preptin: A new bone metabolic parameter? Metabolites 13(9):991. https:\/\/doi.org\/10.3390\/metabo13090991","journal-title":"Metabolites"},{"issue":"1","key":"2941_CR62","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/2230-8210.146874","volume":"19","author":"M Gutch","year":"2015","unstructured":"Gutch M et al (2015) Assessment of insulin sensitivity\/resistance. Indian J Endocrinol Metabol 19(1):160\u2013164. https:\/\/doi.org\/10.4103\/2230-8210.146874","journal-title":"Indian J Endocrinol Metabol"},{"issue":"4","key":"2941_CR63","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3390\/ijerph19042099","volume":"19","author":"J Kruszewska","year":"2022","unstructured":"Kruszewska J, Laudy-Wiaderny H, Kunicki M (2022) Review of novel potential insulin resistance biomarkers in PCOS patients\u2014The debate is still open. Int J Environ Res Public Health 19(4):2099. https:\/\/doi.org\/10.3390\/ijerph19042099","journal-title":"Int J Environ Res Public Health"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02941-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:33:38Z","timestamp":1790757218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02941-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2941"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02941-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Committee at the College of Science, Charmo University, approved the research protocol. Official permission to conduct the study was also granted by the Sulaymaniyah Directorate of Health. All participants were given a written form of consent before their enrollment in the investigation.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}